Amanote Research
Register
Sign In
14 Day-Sequential, Concomitant, and Hybrid Therapies for First-Line Helicobacter Pylori (H. PYLORI) Eradication: A Network Meta-Analysis
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.03.1292
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2015
Authors
X. Zhao
W. Wu
Publisher
Elsevier BV
Related search
Eradication Therapies for Helicobacter Pylori
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
14-Day Triple, 5-Day Concomitant, and 10-Day Sequential Therapies for Helicobacter Pylori Infection in Seven Latin American Sites: A Randomised Trial
The Lancet
Medicine
Comparison of Levofloxacin-Based, 10-Day Sequential Therapy With 14-Day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
Middle East Journal of Digestive Diseases
Hepatology
Gastroenterology
Helicobacter Pylori Eradication?
Gastroenterology
Hepatology
Gastroenterology
Esomeprazole-Based Sequential Therapy and Probiotic for Helicobacter Pylori Eradication
Scripta Scientifica Medica
Lactobacillus Reuteri – An Alternative in the First-Line of Helicobacter Pylori Eradication
Farmacia
Toxicology
Pharmaceutics
Pharmacology
Efficacy of Helicobacter Pylori Eradication Therapies: A Single Centre Observational Study
BMC Gastroenterology
Medicine
Gastroenterology
Correction To: Concomitant, Sequential, and 7-Day Triple Therapy in First-Line Treatment of Helicobacter Pylori Infection in Korea: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
First-Line Helicobacter Pylori Eradication in Patients With Chronic Kidney Diseases in Taiwan
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
